New lens implant aims to sharpen sight after cataracts

NCT ID NCT07502456

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new type of artificial lens, called the Clareon TruPlus, for people having cataract surgery. The lens is placed inside the eye to replace the cloudy natural lens and help restore clear vision. About 122 adults with cataracts and astigmatism will receive the implant in both eyes. The goal is to check how well the lens works and if it is safe over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Clareon TruPlus intraocular lens (IOL) implant
What this could lead to
If successful, this could provide a new option for clear distance vision after cataract surgery, with a slightly extended depth of focus compared to standard lenses.
What could go wrong
This is a small, early-stage study with no control group, so results may not apply to everyone. Risks include typical surgical complications like infection or lens dislocation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHAKIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Berkeley Eye Center

    RECRUITING

    Sugar Land, Texas, 77478, United States

  • Carolina Eyecare Physicians LLC

    RECRUITING

    Mt. Pleasant, South Carolina, 29464, United States

  • Cleveland Eye Clinic

    RECRUITING

    Brecksville, Ohio, 44141, United States

  • Eye Doctors of Arizona

    RECRUITING

    Phoenix, Arizona, 85028, United States

  • The Eye Institute of Utah

    RECRUITING

    Salt Lake City, Utah, 84107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.